“…Out the 74 selected studies, 50 were conducted on patients affected by psychotic, mood and anxiety disorders (SZ, psychosis, MDD, BD, PTSD, anxiety/GAD; Supplementary Tables S1, S2). In particular, 13 studies included patients affected by SZ (Lysaker et al, 2001(Lysaker et al, , 2002Schenkel et al, 2005;Shannon et al, 2011;McCabe et al, 2012;Kelly et al, 2016;Li et al, 2017;Ruby et al, 2017;Kilian et al, 2018;Mørkved et al, 2020;Wells et al, 2020;De-Nardin et al, 2021;Kasznia et al, 2021), and 12 were conducted in patients with ultrahigh risk of psychosis (Üçok et al, 2015;Velikonja et al, 2019Velikonja et al, , 2021 or in patients with first-episode psychosis, FEP (Aas et al, 2011(Aas et al, , 2012bSideli et al, 2014;Ayesa-Arriola et al, 2020) or patients with psychosis (Garcia et al, 2016;van Os et al, 2017;Mansueto et al, 2018Mansueto et al, , 2019Schalinski et al, 2018). Four studies included patients affected by BD (Bücker et al, 2013;Jiménez et al, 2017;Martins et al, 2019;Hsieh et al, 2020), 6 studies were conducted in patients with MDD (Gould et al, 2012;Dannehl et al, 2017;Saleh et al, 2017;Kaczmarczyk et al, 2018;Chakrabarty et al, 2020;Goltermann et al, 2021), while 9 studies included subjects with PTSD…”